(Million Yen)

Shareholders' equity

FY2022

(3/2023)

FY2023

(3/2024)

FY2024

(3/2025)

Share capital

Balance at beginning of period

2,514

2,514

2,514

Total Changes during period

Balance at end of period

2,514

2,514

2,514

Capital surplus

Balance at beginning of period

3,382

3,403

2,979

Changes during period

Disposal of treasury shares

21

18

27

Cancellation of treasury shares

(1,294)

(1,294)

Transfer from retained earnings to capital surplus

852

1,267

Purchase of shares of consolidated subsidiaries

Total Changes during period

21

(424)

Balance at end of period

3,403

2,979

2,979

Retained earnings

Balance at beginning of period

16,765

19,105

20,897

Changes during period

Dividends of surplus

(989)

(1,083)

(1,339)

Profit attributable to owners of parent

3,328

3,728

4,405

Transfer from retained earnings to capital surplus

(852)

(1,267)

Change of scope of equity method

Total Changes during period

2,339

1,792

1,799

Balance at end of period

19,105

20,897

22,696

Treasury shares

Balance at beginning of period

(2,184)

(2,150)

(1,813)

Changes during period

Purchase of treasury shares

0

(995)

0

Disposal of treasury shares

34

38

27

Cancellation of treasury shares

1,294

1,294

Total Changes during period

33

337

1,321

Balance at end of period

(2,150)

(1,813)

(491)

Total shareholders' equity

Balance at beginning of period

20,478

22,873

24,579

Changes during period

Dividends of surplus

(989)

(1,083)

(1,339)

Profit attributable to owners of parent

3,328

3,728

4,405

Purchase of treasury shares

0

(995)

Disposal of treasury shares

55

56

54

Cancellation of treasury shares

Change of scope of equity method

Purchase of shares of consolidated subsidiaries

Total Changes during period

2,394

1,705

3,120

Balance at end of period

22,873

24,579

27,699

Accumulated other comprehensive income

FY2022

(3/2023)

FY2023

(3/2024)

FY2024

(3/2025)

Valuation difference on available-forsale securities

Balance at beginning of period

1,624

1,488

2,920

Changes during period

Net changes in items other than shareholders’ equity

(136)

1,431

65

Total Changes during period

(136)

1,431

65

Balance at end of period

1,488

2,920

2,986

Foreign currency translation adjustment

Balance at beginning of period

11

18

26

Changes during period

Net changes in items other than shareholders’ equity

6

8

(5)

Total Changes during period

6

8

(5)

Balance at end of period

18

26

20

Remeasurements of defined benefit plans

Balance at beginning of period

19

69

155

Changes during period

Net changes in items other than shareholders’ equity

50

85

(46)

Total Changes during period

50

85

(46)

Balance at end of period

69

155

108

Total accumulated other comprehensive income

Balance at beginning of period

1,655

1,576

3,102

Changes during period

Net changes in items other than shareholders’ equity

(79)

1,525

13

Total Changes during period

(79)

1,525

13

Balance at end of period

1,576

3,102

3,115

Subscription rights to shares

FY2022

(3/2023)

FY2023

(3/2024)

FY2024

(3/2025)

Balance at beginning of period

Changes during period

Net changes in items other than shareholders’ equity

Total Changes during period

Balance at end of period

Total net assets

FY2022

(3/2023)

FY2023

(3/2024)

FY2024

(3/2025)

Balance at beginning of period

22,134

24,449

27,681

Changes during period

Dividends of surplus

(989)

(1,083)

(1,339)

Profit attributable to owners of parent

3,328

3,728

4,405

Purchase of treasury shares

0

(995)

Disposal of treasury shares

55

56

54

Cancellation of treasury shares

Change of scope of equity method

Purchase of shares of consolidated subsidiaries

Net changes in items other than shareholders’ equity

(79)

1,525

13

Total Changes during period

2,315

3,231

3,134

Balance at end of period

24,449

27,681

30,815